Navigation Links
Dornier Holmium Laser for Urological Procedures

ProductsDornier Holmium Laser for Urological Procedures
Company Dornier MedTech
Item Dornier Holmium Laser for Urological Procedures
Features Key Indications:
  • Fragmentation of ureteric stones
  • Cystolithotripsy of bladder stones
  • Intrarenal neoplasias
  • Ureter and urethra strictures
  • Vesicle tumors
Description Dornier Holmium Laser for Urological Procedures
Info Dornier MedTech
Customer Service: (800) 367-6437
Web site: http://www.dornier.com/index.html

Related medicine products :

1. Dornier Medilas D Fibertom Endovenous Laser Treatment
2. Dornier Lithotripter S II
3. Dornier Compact Delta
4. Dornier Compact Sigma
5. R 2000Holmium:YAG Laser System
6. StoneLight Holmium laser
7. Megabeam Non-Contact Fibers for Holmium Lasers
8. Full Handle Laseredge Stab Blade Knife, 15 blade
9. Full Handle Laseredge Stab Blade Knife, 15 blade, 3 mm
10. Full Handle Laseredge Stab Blade Knife, 22.5 blade
11. Full Handle Laseredge Stab Blade Knife, 45 blade
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products:
(Date:9/4/2008)... develop sequence of instructions they say could h... Sept. 4 (HealthDay News) -- Vaccine safety expert...cines can receive vaccinations with close monitori...ing in the September issue of Pediatrics , a team...nter put forth a step-by-step set of instructions ...
(Date:9/4/2008)...ls want stronger labeling about fungal infection r...ws) -- Federal health authorities have asked the m... drugs to bolster safety warnings on the risk of d...e drugs, Humira, Cimzia, Enbrel and Remicade, belo...is factor alpha blockers (TNF-alpha blockers), whi...
(Date:9/4/2008)...ical and Naturals Pavilions are Sold-Out and Susta...-Represented, NEW YORK, Sept. 4 /PRNewswire/ -- T...equipment, naturals products, and sustainable,pack...(http://www.hbaexpo.com ),September 9, 10, 11 at ...,Both the Technical and Naturals Pavilions at the ...
(Date:9/4/2008)...ecial display of Palestinian and Israeli teenagers...wswire-USNewswire/ -- America must take a major,ro...violence in the world,says Ira Magaziner, chair o...nd former Senior White House Advisor for Policy De...be the keynote speaker at a conference at,Massachu...
Breaking Medicine News(10 mins):Health News:Even Kids With Known Allergies Can Be Safely Vaccinated 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 2Health News:FDA Demands Tougher Warnings on Immunosuppressive Drugs 3Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 2Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 2Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 3Health News:Ira Magaziner Joins Leaders in Peace Psychology at MSPP to Explore Ways to Transform Violence, Heal Families, Communities and World 4
...test study reports that kids with asthma are more ...due to life events like moving or family relations...hree years were studied . None had a history of ch...asthma diaries, recording asthma attacks and resul...
...carb diets do a better job of keeping metabolism o...and that might be helping people keep the pounds o...rbohydrates such as white bread, refined breakfast...gested, causing a quick rise in blood sugar and in...
...uming over-the-counter non-steroidal anti-inflamma...associated with osteoarthritis, // say researchers...the drugs to placebos. The study involved nearly ...AIDs, and around 3,000 received placebos. The aver...
...emia patients in need of a bone marrow transplant ...gs of a recent study // .Researchers say stem cell...eople who don’t have a sibling to serve as a bone ...uitable unrelated donor in bone marrow registries....
Other Medicine News:
(Date:9/5/2008)...Extracted From a Simple Blood Draw Have,the Potent...a Wide Range of Indic...Genomics is Currently Developing a B...Israel and JERSEY CITY, New Jersey, September 5,/P...SDQ: ROSG), a leader in,the development of microRN...
(Date:9/4/2008)...eal-time PCR testing for the diagnostic ...ept. 4 /- The U.S. Food & Drug,Admini...Man(R) HBV Test,the first assay for quantitating ...t uses Roche,s real-time PCR technology to quantif...,s blood. Doctors may use viral load,testing resul...
(Date:9/4/2008)...Women at More Than 100 Sites in the U.S., ANN ARB...uticals, a,privately-held biopharmaceutical compan...compounds to treat endocrine, metabolic and,cardio...itiated a second,Phase 3 clinical trial of Ophena(...ree oral therapy in development for the treatment ...
(Date:9/4/2008)...tification for Targeted Therapies Tha...TINGTON BEACH, Calif., and AMSTERDAM, Netherlands,...n molecular cancer diagnostics,today announced th...that,allows physicians to quantitatively determine...or (ER), progesterone receptor (PR) and Human Epid...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Crystal 28eye 29 ball 3A Study says visual system equipped with future seeing powers 3326 1Crystal 28eye 29 ball 3A Study says visual system equipped with future seeing powers 3326 2Crystal 28eye 29 ball 3A Study says visual system equipped with future seeing powers 3326 3Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 1Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 2Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 3Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 4Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 5Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 6Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 7Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 8Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 9Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 10Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 11Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 12Sharps Compliance Corp Announces Results for Third Quarter of Fiscal Year 2008 19473 13Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference 19468 1Somanetics Corporation to Present at Citigroup 2008 Healthcare Conference 19468 2Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2079 1Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2079 2
...ech (ACTI.ST), today,announced new positive clinic...reatment of prostate cancer. , By step-wise dose e...ieved, which corresponds to a doubling of the prev... of 0.5 mg/day. This,means that a step-wise intra-... to be administered in future clinical trials. , "...
...eragenix Pharmaceuticals,Inc. (OTCBB:CGXP), a bio...se and dermatology, today announced that a cathete...irtually no biofilm,formation in a 21 day study., ...Ceragenins,were soaked daily in a phosphate-suffer...ay 21, the catheters were challenged with,an inocu...
Other Medicine Technology:Positive Clinical Data for TASQ - Active Biotech's Novel Treatment,of Prostate Cancer 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3